Traded Mar 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Feb 10, 2026 · Filed Feb 12, 2026
Exponent's VP Global Offices & Innovation sold $26K of Exponent shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$25,894
Shares × reported transaction price
5 days after results of Feb 5, 2026, 79 days before results of Apr 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.0% | +1.1% | +3.9% |
| 30 days | −0.1% | −1.9% | +1.8% |
| 90 days | −19.6% | +9.7% | −29.4% |
| 180 days | +1.3% | +13.3% | −12.0% |
Past results only. Not a forecast.
Traded Mar 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Traded Mar 11 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Mar 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.